System Xc-: a key regulatory target of ferroptosis in cancer

Invest New Drugs. 2021 Aug;39(4):1123-1131. doi: 10.1007/s10637-021-01070-0. Epub 2021 Jan 27.

Abstract

Ferroptosis is a type of oxidative stress-dependent regulated necrosis characterized by excessive lipid peroxide accumulation. This novel cell death modality has been implicated in preventing cancer progression. Cancer cells tend to modulate their redox state to prevent excessive peroxidation, eventually facilitating tumor growth. System Xc- (a cystine/glutamate antiporter system) is a promising target in cancer cells for ferroptosis induction. The overexpression of system Xc-, especially its core subunit xCT, has been reported in several tumors, and these high expression levels were closely related to cancer cell proliferation, invasion, metastasis and the tumor microenvironment. xCT might serve as a novel biomarker, and its upregulation almost always indicates drug tolerance and poor survival. Therefore, system Xc- inhibition may enhance chemotherapy sensitivity and optimize patient prognosis. Here, we elaborate on the mediation of ferroptosis by suppressing system Xc- and the relevant underlying molecular mechanism in cancer cells. The spotlight on this approach to cancer treatment is creating a new horizon and pointing to future opportunities.

Keywords: Ferroptosis; System Xc−; cancer treatment; xCT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Transport System y+ / metabolism
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / physiology
  • Ferroptosis / drug effects*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Oxidation-Reduction
  • Oxidative Stress / physiology

Substances

  • Amino Acid Transport System y+
  • Antineoplastic Agents
  • SLC7A11 protein, human